INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Building A Gold Standard Trial Experience In Japan
Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.
-
How Remote Pharmacy Monitoring Improves Trial Compliance
Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.
-
One Program. Many Studies: How Experts Keep It All Aligned.
Compare the differences between project and program management in drug development, and how an integrated CRO ensures oversight and continuity from early development through clinical execution.
-
Creating Operational Efficiency And Competitive Edge
Site networks offer a strategic approach to oncology clinical trials by accelerating study startup and expanding access to diverse patient populations.
-
Breaking Silos In Drug Development: The Power Of An Integrated Model5/11/2026
Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.
-
Patient Payments And Travel8/5/2026
Eliminate financial and travel hurdles for trial participants. Unify payments and travel logistics to reduce site burden, boost participant retention, and run seamless studies.
-
Considerations For Subcutaneous, Intramuscular Formulation Development8/7/2025
Explore the changing landscape of parenteral delivery, considering the pros and cons of intravenous, subcutaneous, and intramuscular formulations, and how new technologies are reshaping drug delivery.
-
How A Biotech Startup Transformed Its Clinical Trial Supply Management2/25/2026
Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
TPDs: Developing The Next Generation Of Oral Therapeutics10/20/2025
Targeted Protein Degraders are a revolutionary drug class with challenges in bioavailability and formulation complexity. Strategic CDMO partnerships are key to successful, scalable development.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
-
For successful regulatory outcomes, we provide quality medical writing services for clinical trial documents, safety updates, and marketing applications.
-
Maximize growth with strategic site selection and incentives advisory that help reduce project costs and optimize expansion, unlocking long-term business value.
-
Simplify patient support in clinical trials through comprehensive expense management, travel coordination, and site services designed to reduce the burden on sites and participants.